As seen on:
As seen on:














Latest Articles
We can’t control the price of a share, but we have control over our choice of companies to invest in.
Raffles Medical Group’s 2023 Net Profit Tumbles 37% Year on Year: 5 Highlights from the Integrated Healthcare Player’s Latest Earnings
The integrated healthcare player sees better days ahead with its latest Vietnam hospital acquisition.
A low currency doesn’t necessarily reflect weakness.
These four REITs are hovering near their 52-week lows. Do we sniff a bargain in any of them?
The moment of truth is coming for AI — but are customers buying it?
These four blue chips have announced higher profits and an increase in their dividend payout.
Popular
PM Lee Announced Major Changes to HDB BTO Classification: These Stocks May be Impacted
The government has abandoned its decades-old HDB classification system. This change may have implications for this crop of stocks.
The secret to effortless investing.
Top Stock Market Highlights of the Week: Manulife US REIT, SATS, China Cuts Interest Rates and Sea Limited
We review the earnings for an aviation stock and technology business and look at the latest economic numbers out of China.
Stability and predictability are traits that are highly sought after by investors.
Stocks
If you have S$40,000 to spare, here are four promising blue-chip stocks you can buy.
With a recovery expected for the semiconductor sector next year, here are five stocks that could benefit.
Raffles Medical Group’s Share Price is Near its 52-Week Low: Is the Healthcare Player a Bargain?
The integrated healthcare player is going through a tough period but could see better earnings in the years to come.
Here are three resilient blue-chip stocks with dividend yields of 5.7% and above.